Fleming Zachary B.

SEC source: 0001493152-24-009564 · ownership.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,854

F1 · shares: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 7, 2025, 2026 and 2027, respectively.

SEC source: 0001493152-24-008909 · ownership.xml · nonDerivative · entry 2

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,161

F2 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 2,329 shares of restricted stock granted to the reporting person on March 2, 2023. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F2 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 2,329 shares of restricted stock granted to the reporting person on March 2, 2023. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-24-008909 · ownership.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,951

F1 · shares: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 2,944 shares of restricted stock granted to the reporting person on March 8, 2022. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F1 · price: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 2,944 shares of restricted stock granted to the reporting person on March 8, 2022. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-24-004972 · ownership.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,877

F1 · shares: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,331 shares of restricted stock granted to the reporting person on December 22, 2021. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F1 · price: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,331 shares of restricted stock granted to the reporting person on December 22, 2021. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-24-000291 · ownership.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,304

F1 · shares: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 3,333 shares of restricted stock granted to the reporting person on January 1, 2022. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F1 · price: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 3,333 shares of restricted stock granted to the reporting person on January 1, 2022. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-23-033453 · ownership.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,559

F1 · shares: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,736 shares of restricted stock granted to the reporting person on March 2, 2023. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F1 · price: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,736 shares of restricted stock granted to the reporting person on March 2, 2023. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-23-008369 · ownership.xml · nonDerivative · entry 4

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,243

F4 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 2,943 shares of restricted stock granted to the reporting person on March 8, 2022. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F4 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 2,943 shares of restricted stock granted to the reporting person on March 8, 2022. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-23-008369 · ownership.xml · nonDerivative · entry 3

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,960

F3 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,331 shares of restricted stock granted to the reporting person on December 22, 2021. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F3 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,331 shares of restricted stock granted to the reporting person on December 22, 2021. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-23-008369 · ownership.xml · nonDerivative · entry 2

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,285

F2 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 3,333 shares of restricted stock granted to the reporting person on December 9, 2021. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F2 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 3,333 shares of restricted stock granted to the reporting person on December 9, 2021. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-23-008369 · ownership.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,097

F1 · shares: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 4,519 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F1 · price: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 4,519 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-23-006855 · ownership.xml · nonDerivative · entry 2

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,198

F2 · shares: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long Term Incentive Plan. The restricted stock will vest in full on September 1, 2023.

SEC source: 0001493152-23-006855 · ownership.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,462

F1 · shares: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 1, 2024, 2025 and 2026, respectively.

SEC source: 0001493152-22-034634 · ownership.xml · nonDerivative · entry 2

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,474

F2 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,331 shares of restricted stock granted to the reporting person on December 22, 2021. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F2 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,331 shares of restricted stock granted to the reporting person on December 22, 2021. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-22-034634 · ownership.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,799

F1 · shares: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 6,035 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F1 · price: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 6,035 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-22-031349 · ownership.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,270

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2022.

SEC source: 0001493152-22-030994 · ownership.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,687

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2022.

SEC source: 0001493152-22-030674 · ownership.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,250

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2022.

SEC source: 0001493152-22-018830 · ownership.xml · nonDerivative · entry 3

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,270

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2022.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.28, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.

SEC source: 0001493152-22-018830 · ownership.xml · nonDerivative · entry 2

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,020

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2022.

SEC source: 0001493152-22-018830 · ownership.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,685

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $22.00, inclusive. The reporting person undertakes to provide to Sanara MedTech Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.

SEC source: 0001493152-22-018253 · ownership.xml · nonDerivative · entry 2

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,950

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2022.

SEC source: 0001493152-22-018253 · ownership.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,244

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2022.

SEC source: 0001493152-22-017958 · ownership.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,313

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.08, inclusive. The reporting person undertakes to provide to Sanara MedTech Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.

SEC source: 0001493152-22-006531 · ownership.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,770

F1 · shares: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 1, 2023, 2024 and 2025, respectively.

SEC source: 0001493152-22-000338 · ownership.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,939

F1 · shares: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The restricted stock will vest in three equal installments, with one-third of the shares vesting on January 1, 2023, 2024 and 2025, respectively.

SEC source: 0001493152-21-032524 · ownership.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · President - Surgical Div.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,939

F1 · shares: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The restricted stock will vest in three installments, with one-third of the shares vesting on February 1, 2022, and the remainder vesting in two equal installments on February 1, 2023 and 2024, respectively.

SEC source: 0001493152-21-032040 · ownership.xml · nonDerivative · entry 3

Fleming Zachary B. · CIK 0001799602 · President - Surgical Div.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,946

F3 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 801 shares of restricted stock granted to the reporting person on September 30, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F3 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 801 shares of restricted stock granted to the reporting person on September 30, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-21-032040 · ownership.xml · nonDerivative · entry 2

Fleming Zachary B. · CIK 0001799602 · President - Surgical Div.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,142

F2 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 802 shares of restricted stock granted to the reporting person on September 30, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F2 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 802 shares of restricted stock granted to the reporting person on September 30, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001493152-21-032040 · ownership.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · President - Surgical Div.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,338

F1 · shares: Represents shares of common stock of Sanara MedTech, Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,517 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

F1 · price: Represents shares of common stock of Sanara MedTech, Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,517 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

SEC source: 0001654954-21-011412 · section16.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · President - Surgical Div.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,708

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2021.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.89 to $34.25, inclusive. The reporting person undertakes to provide to Sanara MedTech Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

SEC source: 0001654954-21-010890 · section16.xml · nonDerivative · entry 2

Fleming Zachary B. · CIK 0001799602 · President - Surgical Div.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,708

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2021.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.10 to $33.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.

SEC source: 0001654954-21-010890 · section16.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · President - Surgical Div.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,237

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2021.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.07 to $33.01, inclusive. The reporting person undertakes to provide to Sanara MedTech Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

SEC source: 0000897423-20-000096 · edgar.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · President - Surgical Div.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,708

SEC source: 0000897423-20-000058 · edgar.xml · nonDerivative · entry 2

Fleming Zachary B. · CIK 0001799602 · President - Surgical Div.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,105

SEC source: 0000897423-20-000058 · edgar.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · President - Surgical Div.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,550

SEC source: 0000897423-20-000048 · edgar.xml · nonDerivative · entry 2

Fleming Zachary B. · CIK 0001799602 · President - Surgical Div.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F2 · kind: On January 7, 2020 the Issuer's Board of Directors approved the grant to the Reporting Person of 13,555 shares of restricted stock to be effective January 21, 2020, subject to specified conditions, but prior to the completion of the grant and the issuance of such shares, the Issuer's Board of Directors, on February 10, 2020, rescinded the grant of all such shares of the restricted stock.

F2 · price: On January 7, 2020 the Issuer's Board of Directors approved the grant to the Reporting Person of 13,555 shares of restricted stock to be effective January 21, 2020, subject to specified conditions, but prior to the completion of the grant and the issuance of such shares, the Issuer's Board of Directors, on February 10, 2020, rescinded the grant of all such shares of the restricted stock.

SEC source: 0000897423-20-000048 · edgar.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · President - Surgical Div.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,555

F1 · kind: On January 7, 2020 the Issuer's Board of Directors approved the grant to the Reporting Person of 4,550 shares of restricted stock to be effective January 21, 2020, subject to specified conditions, but prior to the completion of the grant and the issuance of such shares, the Issuer's Board of Directors, on February 10, 2020, rescinded the grant of all such shares of the restricted stock.

F1 · price: On January 7, 2020 the Issuer's Board of Directors approved the grant to the Reporting Person of 4,550 shares of restricted stock to be effective January 21, 2020, subject to specified conditions, but prior to the completion of the grant and the issuance of such shares, the Issuer's Board of Directors, on February 10, 2020, rescinded the grant of all such shares of the restricted stock.

SEC source: 0000897423-20-000016 · edgar.xml · nonDerivative · entry 2

Fleming Zachary B. · CIK 0001799602 · President - Surgical Div.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,105

SEC source: 0000897423-20-000016 · edgar.xml · nonDerivative · entry 1

Fleming Zachary B. · CIK 0001799602 · President - Surgical Div.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,550